Cleared Traditional

Straumann BLX Gold Abutments (K200597) - FDA 510(k) Clearance

Class II Dental device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200597 · Straumann USA, LLC (On Behalf of Institut Straumann Ag) · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
163d
Days
Class 2
Risk

K200597 is an FDA 510(k) clearance for the Straumann BLX Gold Abutments. Classified as Abutment, Implant, Dental, Endosseous within the NHA classification (a category for dental implant abutments and prosthetic components), Class II - Special Controls.

Submitted by Straumann USA, LLC (On Behalf of Institut Straumann Ag) (Andover, US). The FDA issued a Cleared decision on August 19, 2020 after a review of 163 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3630 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Straumann USA, LLC (On Behalf of Institut Straumann Ag) devices

Submission Details

510(k) Number K200597 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 2020
Decision Date August 19, 2020
Days to Decision 163 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d slower than avg
Panel avg: 127d · This submission: 163d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NHA Abutment, Implant, Dental, Endosseous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3630
Definition To Be Used In Conjunction With An Endosseous Dental Implant Fixture To Aid In Prosthetic Rehabilitation.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - NHA Abutment, Implant, Dental, Endosseous

All 315
Devices cleared under the same product code (NHA) and FDA review panel - the closest regulatory comparables to K200597.
Telio CAD Abutment Solutions- extra systems
K193193 · Ivoclar Vivadent, AG · Nov 2020
TIB Abutment System
K193084 · Southern Implants (Pty), Ltd. · Oct 2020
LOCATOR R-Tx
K200827 · Ivory Super Holdco, Incp. · Sep 2020
Sirona Dental CAD/CAM System with CEREC Chairside Software
K193408 · Dentsply Sirona · Aug 2020
Straumann® Retentive System – Novaloc TiN Abutments
K193046 · Institut Straumann AG · Aug 2020
Duranext Abutments
K200355 · Elegant Dental Corp. · Jul 2020